Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

Promising outcomes from a cognitive behavioral therapy text-messaging intervention targeting drug use, antiretroviral therapy adherence, and HIV risk behaviors among adults living with HIV and substance use disorders

We developed and evaluated a 12-week, CBT-based text-messaging intervention (TXT-CBT) targeting drug use and adherence to antiretroviral therapy (ART) for adults with HIV and comorbid opioid and stimu

Original research | 2021

About PWUD, Outcomes, Illegal drugs, Stimulants, Digital health

Québec Guide to Improving Practices in the Management of Opioid Use Disorder

Guidelines | 2020

Clinical guidance, Harm reduction, Safer supply, About prescribers, Substitution/OAT, Transitions in care/treatment

Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder

Studied outcomes of buprenorphine treatment delivered in jail settings

Original research | 2022

Mortality, Harm reduction, Crime, Legal system/law enforcement, Substitution/OAT

Scoping review of interventions to link individuals to substance use services at discharge from jail

This scoping review identified 14 studies (28 affiliated publications) that used experimental or quasi-experimental designs to evaluate jail re-entry interventions for individuals with SUD.

Scoping review | 2021

Harm reduction, About PWUD, Social services, Legal system/law enforcement, Transitions in care/treatment

Stimulant safe supply: a potential opportunity to respond to the overdose epidemic

Current treatments for stimulant use disorder have limited effectiveness, and even less applicability to the lived realities of marginalized stimulant users.

Commentary | 2020

Policy/Regulatory, Safer supply, Equity, Advocacy, Illegal drugs, Stimulants

The impact of social network dynamics on engagement in drug use reduction programs among men and women who use drugs

The current study examined associations between longitudinal changes in egocentric social networks of male and female people who use drugs (PWUD) and engagement in drug use reduction programs, broadly

Original research | 2021

Wrap-around services, About PWUD, Outcomes, Illegal drugs, Sex/Gender

The state of science on including inhalation within supervised consumption services: A scoping review of academic and grey literature

We aimed to: (1) synthesize the literature on including inhalation or other forms of non-injection drug use (e.g., oral, intranasal) within SCS; (2) describe the state of the science on the feasibilit

Lit review | 2022

Harm reduction, Policy/Regulatory, About PWUD, Illegal drugs, SCS/OPS

Trends in Hospitalizations for Serious Infections Among People With Opioid Use Disorder in Ontario, Canada

Opioid use among people who inject drugs can lead to serious complications, including infections.

Original research | 2021

Mortality, Harm reduction, About PWUD, Illegal drugs, Hospitals

A systematic review of post-release programs for women exiting prison with substance-use disorders: assessing current programs and weighing the evidence

Unlike men, women in prison are characterised by significant histories of trauma, poor mental health, and high rates of substance use disorders (SUDs).

Lit review | 2022

Harm reduction, Wrap-around services, Legal system/law enforcement, Sex/Gender

Acute pain and self-directed discharge among hospitalized patients with opioid-related diagnoses: a cohort study

Inadequate pain management has been identified as a potential motivator of self-directed discharge in this patient population.

Original research | 2021

About PWUD, Outcomes, Housing, Chronic pain, Mental health, Hospitals

Canada’s hidden opioid crisis: the health care system’s inability to manage high-dose opioid patients

Commentary | 2019

Policy/Regulatory, About prescribers, Chronic pain

Changes in the Availability of Medications for Opioid Use Disorder in Prisons and Jails in the United States During the COVID-19 Pandemic

During the COVID-19 pandemic, federal agencies relaxed buprenorphine prescribing restrictions including for incarcerated individuals. The impact of COVID-19 on the supply of MOUD in U.S.

Original research | 2022

Policy/Regulatory, Legal system/law enforcement, Substitution/OAT

Characteristics of fatal ‘novel’ synthetic opioid toxicity in Australia

Aims: To determine 1. The characteristics of all recorded cases of fatal drug poisoning involving novel synthetic opioids (NSOs) in Australia; 2. The toxicology of cases; and 3.

Original research | 2022

Overdose, Mortality, About PWUD, Outcomes, Illegal drugs, Drug checking

Efficacy of Heroin-Assisted Treatment in Belgium: A Randomised Controlled Trial

Heroin-assisted treatment (HAT) can improve the condition of heroin addicts still using street heroin after a methadone treatment.

Original research | 2015

Evidence base, Safer supply, About PWUD, Outcomes, Crime, Illegal drugs, Substitution/OAT

Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients’ and prescribers’ experiences with changes in unsupervised dosing

The Ontario COVID-19 OAT Treatment Guidance document was developed to facilitate access to OAT and continuity of care during the pandemic, while supporting physical distancing measures.

Original research | 2021

Evidence base, Policy/Regulatory, Hesitancy of prescribers , Safer supply, Advocacy, About prescribers, About PWUD, Substitution/OAT

Harm reduction must be recognised an essential public health intervention during crises

Commentary | 2021

Policy/Regulatory, Illegal drugs

La pratique émergente de la pharmacothérapie de remplacement

Report | 2021

Harm reduction, Safer supply, About prescribers

Managing a client who is angry or aggressive

If a client becomes aggressive, threatening or potentially violent, it is important for service providers to respond in accordance with the policies and procedures specific to their service.

Webpage | 2016

Harm reduction, About pharmacists, About prescribers, About PWUD, Social services, Illegal drugs, Workplace, SCS/OPS